We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Ford
F
$55.7B
| $340K | ﹤0.01% |
44,446
-32,256
| -42% | -$287K |
|
1927
Western Union
WU
$2.21B
| $339K | ﹤0.01% |
19,847
+8,106
| +69% | +$147K |
|
1928
Triumph Financial Inc
TFIN
$1.82B
| $337K | ﹤0.01% |
11,350
-110,868
| -91% | -$3.91M |
|
|
IMGN
1929
DELISTED
Immunogen Inc
IMGN
| $336K | ﹤0.01% |
70,061
-1,491
| -2% | -$9.05K |
|
1930
James River Group Holdings
JRVR
$217M
| $334K | ﹤0.01% |
9,131
-6,674
| -42% | -$254K |
|
|
UBNK
1931
DELISTED
United Financial Bancorp, Inc.
UBNK
| $334K | ﹤0.01% |
22,706
-14,976
| -40% | -$236K |
|
|
MNR
1932
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $334K | ﹤0.01% |
26,945
-37,669
| -58% | -$548K |
|
1933
Ezcorp Inc
EZPW
$1.71B
| $333K | ﹤0.01% |
43,052
-13,401
| -24% | -$127K |
|
1934
AptarGroup
ATR
$8.61B
| $332K | ﹤0.01% |
3,528
+190
| +6% | +$19.4K |
|
1935
Huron Consulting
HURN
$2.42B
| $332K | ﹤0.01% |
+6,469
| New | +$329K |
|
|
BFS
1936
Saul Centers
BFS
$841M
| $331K | ﹤0.01% |
7,013
-2,125
| -23% | -$109K |
|
1937
Larimar Therapeutics
LRMR
$432M
| $331K | ﹤0.01% |
5,573
+2,144
| +63% | +$212K |
|
|
ARQL
1938
DELISTED
Arqule Inc
ARQL
| $331K | ﹤0.01% |
119,517
| – | – |
|
1939
Simmons First National
SFNC
$3.39B
| $330K | ﹤0.01% |
13,661
-4,443
| -25% | -$120K |
|
|
ALX
1940
Alexander's
ALX
$1.41B
| $329K | ﹤0.01% |
1,079
-643
| -37% | -$205K |
|
1941
Starwood Property Trust
STWD
$6.09B
| $329K | ﹤0.01% |
16,670
-38,590
| -70% | -$832K |
|
1942
Center Bancorp
CNOB
$1.78B
| $327K | ﹤0.01% |
17,729
-148
| -0.8% | -$3.03K |
|
1943
ANI Pharmaceuticals
ANIP
$1.78B
| $326K | ﹤0.01% |
7,240
-2,552
| -26% | -$134K |
|
1944
Dorman Products
DORM
$4.18B
| $324K | ﹤0.01% |
+3,601
| New | +$288K |
|
1945
Howard Hughes
HHH
$4.03B
| $324K | ﹤0.01% |
3,476
-3,291
| -49% | -$342K |
|
1946
Annaly Capital Management
NLY
$17.4B
| $323K | ﹤0.01% |
8,225
+1,002
| +14% | +$40.1K |
|
1947
Tesla
TSLA
$1.3T
| $321K | ﹤0.01% |
+14,490
| New | +$312K |
|
1948
Pricesmart
PSMT
$5.46B
| $320K | ﹤0.01% |
+5,409
| New | +$372K |
|
|
ZAYO
1949
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $316K | ﹤0.01% |
13,838
-2,808
| -17% | -$76.9K |
|
|
CASI
1950
DELISTED
CASI Pharmaceuticals
CASI
| $314K | ﹤0.01% |
7,813
-1,057
| -12% | -$40K |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.